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The putative virulence factors of Vibrio vulnificus in-
clude an elastase, the gene product of vvpE. We previ-
ously demonstrated that vvpE expression is differen-
tially directed by two different promoters in a growth
phase-dependent manner. The activity of the stationary-
phase promoter (promoter S (PS)) is dependent on RpoS
and is also under the positive control of cyclic AMP
receptor protein (CRP). In this study, primer extension
analyses revealed that SmcR, the Vibrio harveyi LuxR
homolog, is also involved in the regulation of vvpE tran-
scription by activating PS. Although the influence of
CRP on PS is mediated by SmcR, the level of PS activity
observed when CRP and SmcR function together was
found to be greater than the sum of the PS activities
achieved by each activator alone. Western blot analyses
demonstrated that the cellular levels of RpoS, CRP, and
SmcR were not significantly affected by one other, indi-
cating that CRP and SmcR function cooperatively to
activate PS rather than sequentially in a regulatory cas-
cade. The binding sites for CRP and SmcR were mapped
based on a deletion analysis of the vvpE promoter region
and confirmed by in vitro DNase I protection assays. The
binding sites for CRP and SmcR were juxtapositioned
and centered 220 and 198 bp upstream of the transcrip-
tion start site of PS, respectively. Accordingly, these
results reveal that CRP and SmcR function synergisti-
cally to coactivate the expression of vvpE by the RpoS-
dependent promoter (PS) and that the activators exert
their effect by directly binding to the promoter in the
stationary phase.
The pathogenic marine bacterium Vibrio vulnificus is the
causative agent of food-borne diseases, including life-threaten-
ing septicemia and possibly gastroenteritis, in individuals with
underlying predisposed conditions such as liver damage, excess
levels of iron, and immunocompromised conditions. Wound in-
fections also result from exposure to seawater or from the
handling of shellfish contaminated with V. vulnificus. The mor-
tality from septicemia is very high (50%), and death can occur
within 1–2 days after the first signs of illness. Several potential
virulence factors, including an endotoxin, polysaccharide cap-
sule, iron-sequestering systems, cytolytic hemolysin, elastase,
phospholipase A2, and other exotoxins, have been identified in
V. vulnificus (for recent reviews, see Refs. 1 and 2).
The elastase activity is from a neutral metalloprotease and
represents the major proteolytic activity of V. vulnificus (3, 4).
Our previous study revealed the existence of at least two pro-
teases that are produced by V. vulnificus (5). Therefore, vvpE
was designed to differentiate the elastase gene from other
genes encoding other potential proteases of V. vulnificus (5). As
such, a gene encoding the V. vulnificus elastase was recently
cloned and sequenced by us (5) and by others (6). The deduced
gene product was predicted to be a 609-amino acid polypeptide,
and the mature elastase is a 45-kDa protein consisting of 413
amino acids generated by the deletion of the N-terminal 196
amino acids. Using the mature protease purified from recom-
binant Escherichia coli, two functional domains, a 35-kDa N-
terminal domain required for catalytic activity and 10-kDa
domain required for attachment to substrate, were identified
(7).
The characteristics of elastase as a potential virulence factor
have primarily been studied using the purified protein in ani-
mal models (reviewed in Ref. 8). The injection of purified ela-
stase can reproduce many aspects of the diseases caused by V.
vulnificus, including dermonecrosis, tissue destruction, edema,
and ulceration. These diverse activities are believed to be
caused by the proteolytic degradation or inactivation of biolog-
ically important host proteins and immune system components
such as collagen, fibrin, and complement. Conversely, in-
creased vascular permeability is stimulated by the direct acti-
vation of the Hageman factor and prekallikrein by elastase,
leading to the production of bradykinin. In addition, the activ-
ity of elastase toward host iron-binding proteins is involved in
the utilization of heme and iron.
Compared with the substantial number of reports on the
characterization of purified elastase, there have been only a
few studies on the regulatory mechanism used by the bacte-
rium to modulate the expression of the vvpE gene (9, 10). In a
previous report, we showed that transcription of the vvpE gene
of V. vulnificus is initiated by two different types of promoter,
promoter L (PL)1 and promoter S (PS), in a growth phase-de-
pendent manner (9). The basal level expression of vvpE is
directed by PL, independent of RpoS and cyclic AMP receptor
protein (CRP), and remains low throughout the log and sta-
tionary growth phases. In addition to this basal level, more
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which is under the positive control of both CRP and RpoS. This
differential utilization of two promoters can permit precise
levels of elastase in response to modifications of the environ-
ment and growth stage. Meanwhile, it has been reported that
SmcR, the Vibrio harveyi LuxR homolog, is also involved in the
positive control of vvpE expression (10).
However, until now, no molecular analysis of the role of CRP
and SmcR in vvpE expression has been reported. Neither the
promoter(s) of the vvpE gene activated by SmcR nor the se-
quences upstream of vvpE required for activation by CRP and
SmcR have been previously identified. Furthermore, the ques-
tion of whether the activators directly or indirectly affect vvpE
expression has not yet been addressed. Accordingly, in an effort
to elucidate the regulatory mechanism of vvpE expression at a
molecular level, this study examined the influence of the mu-
tation of smcR on the activity of vvpE promoters. The relation-
ship between RpoS, CRP, and SmcR was also examined by
determining the cellular level of the proteins in an rpoS, crp,
and smcR background. As a result, it was demonstrated that
CRP and SmcR coactivate PS of vvpE in a synergistic and
seemingly growth phase-dependent manner. Finally, the bind-
ing of CRP and SmcR directly to the upstream portion of vvpE
was demonstrated, and the binding sites for CRP and SmcR
were determined.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Culture Media—The strains and plasmids
used in this study are listed in Table I. The E. coli strains used for
plasmid DNA replication or conjugational transfer of plasmids were
grown in LB broth with or without 1.5% (w/v) agar. Unless noted
otherwise, the V. vulnificus strains were grown in LB medium supple-
mented with 2.0% (w/v) NaCl (LBS). When required, appropriate anti-
biotics were added to the media as follows: 100 g/ml ampicillin, 50
g/ml kanamycin, and 10 g/ml tetracycline.
Measurement of Cell Growth and Elastase Activities—Cultures of the
V. vulnificus strains were grown at 30 °C under aeration, and growth
was monitored by measuring the A600 of the cultures. Cultures incu-
bated for 12–16 h (A600  2.0) were harvested, and the elastase activ-
ities in the stationary phase were determined according to previously
described procedures (5). The means  S.E. were calculated from at
least three independent experiments.
General Genetic Methods—Isolation of the plasmid DNA and
genomic DNA and transformations were carried out according to the
procedures described by Sambrook and Russell (11). The restriction and
DNA-modifying enzymes (New England Biolabs Inc., Beverly, MA)
were used as recommended by the manufacturer. The DNA fragments
were purified from agarose gels using a Geneclean II kit (Bio 101, Inc.,
Vista, CA). The primary DNA cloning and manipulation were conducted
in E. coli DH5, and restriction mapping was used to confirm that the
transformants contained the appropriate plasmids. PCR amplification
of the DNA was performed using a GeneAmp PCR 2400 system
(PerkinElmer Life Sciences) and standard protocols.
Generation of smcR::nptI Mutants—A 1.2-kb DNA fragment from V.
vulnificus (ATCC29307) that carried the entire smcR coding region was
cloned into pHS103 2 (Table I). To inactivate smcR in vitro, a 1.2-kb nptI
DNA conferring resistance to kanamycin (12) was inserted into a
unique ClaI site present within the coding region of smcR. The 2.4-kb
smcR::nptI cartridge was then liberated from the resulting construct
(pHS1031) and ligated with SmaI-digested pCVD442 (13) to form
pHS1032 (Table I). To generate the smcR::nptI mutant by homologous
recombination, E. coli SM10 pir, tra (containing pHS1032) (14) was used
as a conjugal donor to V. vulnificus ATCC29307 (see Fig. 1A). For con-
struction of the smcR rpoS or smcR crp double mutant, isogenic mutants
of ATCC29307, which lack either rpoS (KP101)3 or crp (DI0201),2 were
used as the recipients. The conjugation and isolation of the transconju-
gants were conducted using previously described methods (5, 9, 15).
Overexpression and Purification of V. vulnificus SmcR, CRP, and
RpoS—The coding region of smcR was amplified using the chromosomal
2 S. H. Choi, manuscript in preparation.
3 K.-H. Lee, manuscript in preparation.
TABLE I
Strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Ref. or source
Strains
V. vulnificus
ATCC29307 Clinical isolate Laboratory collection
KP101 ATCC29307, rpoS b
DI0201 ATCC29307,crp c
KC74 ATCC29307, crp::nptI 9
HS03 ATCC29307, smcR::nptI This study
HS04 ATCC29307, rpoS, smcR::nptI This study
DI0202 ATCC29307, crp, smcR::nptI This study
E. coli
DH5 supE44 lacU169 (80 lacZ M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Laboratory collection
SM10 pir Thi thr leu tonA lacY supE recA::RP4–2-Tc::Mu pir, oriT of RP4; Kmr; conjugational donor 14
BL21 (DE3) F, ompT, hsdS (rB
, mB
), gal(DE3) Laboratory collection
Plasmids
pRK415 Broad host range vector, IncP ori, oriT of RK2; Tcr 18
pCVD442 R6K  ori, sacB, oriT of RP4; Apr 13
pKC980 pUC18 with vvpE; Apr 5
pHS0001 pRK415 with rpoS; Tcr 9
pKC0004 pRK415 with crp; Tcr 9
pKP001 pQE32 with rpoS; Apr b
pHK0201 pRSET A with crp; Apr 16
pHS103 pUC18 with smcR; Apr c
pHS1031 pHS103 with nptI; Apr, Kmr This study
pHS1032 pCVD442 with smcR::nptI This study
pHS104 pRSET C with smcR; Apr This study
pHS105 pRK415 with smcR; Tcr This study
pHK0011 pRK415 with promoterless luxAB; Tcr 9
pHS201 pHK0011 with 748-bp fragment of vvpE upstream region; Tcr This study
pHS202 pHK0011 with 634-bp fragment of vvpE upstream region; Tcr This study
pHS203 pHK0011 with 620-bp fragment of vvpE upstream region; Tcr This study
pHS204 pHK0011 with 527-bp fragment of vvpE upstream region; Tcr This study
pHS205 pHK0011 with 441-bp fragment of vvpE upstream region; Tcr This study
a Apr, ampicillin-resistant; Kmr, kanamycin-resistant; Tcr, tetracycline-resistant.
b K.-H. Lee, manuscript in preparation.
c S. H. Choi, manuscript in preparation.
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DNA of V. vulnificus ATCC29307 as the template and oligonucleotide
primers His-SmcR001 and His-SmcR002 (see Table II). The 0.6-kb PCR
product was subcloned into a His6 tagging expression vector, pRSET C
(Invitrogen). The resulting plasmid, pHS104, encoded SmcR with a His6
tag at the amino terminus. The His-tagged SmcR protein was then
expressed in E. coli BL21(DE3), and the protein was purified by affinity
chromatography according to the manufacturer’s procedure (QIAGEN
Inc., Valencia, CA). In a similar way, the expression and purification of
His-tagged CRP and His-tagged RpoS were carried out using pHK0201
and pKP001,3 carrying the V. vulnificus crp and rpoS genes, respec-
tively, as described (16).
Western Blot Analysis of V. vulnificus SmcR, CRP, and RpoS Pro-
teins—The purified His-tagged proteins were used to raise primary
antibodies against SmcR, CRP, and RpoS of V. vulnificus. Polyclonal
antibodies specific to each protein were made by immunizing Sprague-
Dawley rats on three occasions at 3-week intervals with 200 g of the
protein for each immunization. Western immunoblotting was per-
formed according to the procedure described previously by Jeong et al.
(5). Briefly, the cellular proteins of the wild type and its isogenic
mutants grown to the log and stationary phases were resolved by
SDS-PAGE (17). The resolved proteins were then transferred to a
nitrocellulose membrane (Bio-Rad) and probed with a 1:5000 dilution of
the rat polyclonal antibodies. The bound antibodies were detected using
goat anti-rat IgG conjugated with alkaline phosphatase (Sigma) and
visualized by incubation with 5-bromo-4-chloro-3-indolyl phosphate/
nitro blue tetrazolium substrate (Sigma) (5).
Transcript Analysis—Total cellular RNA was isolated from the
V. vulnificus strains at different growth phases using a TRIzol reagent
kit (Invitrogen) according to the manufacturer’s specifications. For
the primer extension experiments, an end-labeled 24-base primer
(VVPE9905) complementary to a coding region of vvpE was added to the
RNA and then extended with SuperScript II RNase H reverse tran-
scriptase (Invitrogen) as described previously (9, 16). The cDNA prod-
ucts were then purified and resolved on a sequencing gel alongside
sequencing ladders generated with the same primer used for the primer
extension. The nucleotide sequence for the plasmid DNA of pKC980 (5)
was determined using the dideoxy chain termination method with
TopTM DNA polymerase (Bioneer, Seoul, Korea) following the manufac-
turer’s protocols.
For Northern slot blot analysis, a series of reactions was performed
according to standard procedures (11) with 20 g of total RNA. A 1.2-kb
HindIII-HindIII DNA probe representing the internal sequences of
vvpE was labeled with [-32P]dCTP using a Prime-a-gene labeling sys-
tem (Promega, Madison, WI) and used for hybridization as described
previously (9). The primer extension products and Northern hybridiza-
tion blots were visualized using a phosphorimage analyzer (Model
BAS1500, Fuji Photo Film Co. Ltd., Tokyo, Japan).
Construction of a Set of vvpE-luxAB Transcriptional Fusions—A set
of vvpE-luxAB transcriptional fusion reporters was created by subclon-
ing a series of DNA fragments that overlapped the vvpE promoter
region into pHK0011 (see Fig. 6A) that was carrying promoterless
luxAB luciferase genes (9). The subcloned fragments were amplified by
PCR using pKC980 (5) as the template. Primer VVPE006 (see Table II)
included an XbaI restriction site followed by bases corresponding to the
5-end of the vvpE coding region. VVPE006 was used in conjunction
with one of the following primers to amplify the DNA upstream of vvpE:
VVPE001 (for pHS201), VVPE002 (for pHS202), VVPE003 (for
pHS203), VVPE004 (for pHS204), or VVPE005 (for pHS205) (see Table
II). A KpnI restriction site was added to these primers to facilitate the
cloning of the PCR products. The DNA fragments were digested with
XbaI and KpnI and inserted into pHK0011 that had been digested with
the same enzymes, thereby creating five vvpE-luxAB reporter con-
structs, as confirmed by DNA sequencing. The vvpE-luxAB reporters
were then transferred into ATCC29307 and the isogenic mutants by
conjugation. The cellular luminescence of the cultures was measured
with a luminometer (Lumat Model 9501, Berthold, Wildbad, Germany)
and expressed in arbitrary relative light units as described previously
(9, 16).
Gel Mobility Shift Assay and DNase I Footprinting—The gel shift
assays were performed according to standard procedures (11). The
200-bp upstream region of vvpE, extending from residues300 to101
with respect to the 1 transcription start site, was amplified by PCR
using 32P-labeled VVPE021 and unlabeled VVPE022 as the primers.
The binding of CRP to the labeled DNA and electrophoretic analysis of
the CRPDNA complexes have already been described (16). The protein-
DNA binding reactions with SmcR were the same as those with CRP,
except that cAMP was omitted from the reaction buffer. For competition
analyses, the same but unlabeled 200-bp DNA fragment was used as a
competitor DNA.
For the DNase I protection assays, a 270-bp fragment of the vvpE
promoter region was generated by PCR amplification using a combina-
tion of 32P-labeled and unlabeled primers VVPE023 and VVPE024. The
binding of CRP to the labeled DNA and DNase I digestion of the
CRPDNA complexes was carried out following the procedures de-
scribed previously by Choi et al. (16). After precipitation with ethanol,
the digested DNA products were resolved on a sequencing gel alongside
sequencing ladders of pKC980 generated using either VVPE023 (for the
coding strand) or VVPE024 (for the noncoding strand) as the primer.
Similar experimental conditions were used with SmcR, except that
cAMP was omitted from the reaction buffer for the SmcRDNA complex
formation. The gels were visualized as described for the primer exten-
sion analyses.
RESULTS
Construction and Confirmation of V. vulnificus smcR, smcR
crp, and smcR rpoS Mutants—Previously, it has been sug-
gested that SmcR positively regulates vvpE gene expression in
V. vulnificus (10). Thus, to further examine the regulation of
vvpE by SmcR, V. vulnificus smcR mutants were constructed
by allelic exchange (Fig. 1A). A double crossover in which each
wild-type smcR gene was replaced with an smcR::nptI allele
was confirmed by PCR as shown in Fig. 1B. The PCR analysis
of the genomic DNA from ATCC29307, KP101, and DI0201
using primers SmcR001 and SmcR002 (Table II) produced a
0.6-kb fragment (Fig. 1B); meanwhile, the genomic DNA from
the smcR::nptI mutants resulted in an amplified DNA frag-
ment1.8 kb in length. The 1.8-kb fragment was in agreement
with the projected size of a DNA fragment containing the
wild-type smcR (0.6 kb) and nptI (1.2 kb) genes. The mutants
FIG. 1. Diagram of allelic exchange and confirmation of smcR::nptI mutants. A, homologous recombination between the chromosomal
smcR gene from strain ATCC29307, KP101, or DI0201 and pHS1032. Dashed lines, chromosomal DNA; solid line, plasmid DNA; open boxes, the
target smcR gene; shaded boxes, the nptI gene; open arrows, locations of the oligonucleotide primers used to confirm the nptI insert; 	, crossover.
B, PCR analysis of ATCC29307 and isogenic mutants generated by allelic exchange. Molecular size markers (1-kb ladder, Invitrogen) and PCR
products (in kb) are indicated.
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chosen for further analysis were named HS03 for the smcR
mutant, HS04 for the smcR rpoS double mutant, and DI0202
for the smcR crp double mutant (Fig. 1B and Table I). To
determine the stability of the insertional mutation, the mutant
strains were grown overnight without kanamycin selection.
The inserted nptI DNA was stably maintained as determined
by the sustained kanamycin resistance (all of 500 colonies
tested) and generation of the appropriately sized DNA frag-
ment by PCR (data not shown).
Effect of smcR Mutation on Production of Elastase—When
the smcR mutant HS03 was compared with its parental wild
type during stationary growth, it produced much less elastase,
and the level of elastase activity was almost 10-fold less than in
the wild type (Fig. 2). The vvpE transcript was not apparent in
the smcR mutant, indicating that the effect of SmcR on the
expression of elastase is at the level of transcription. We exam-
ined whether the reintroduction of recombinant smcR could
complement the decrease in elastase activity in HS03. For this
purpose, plasmid pHS105 was constructed by subcloning the
smcR coding region, which was amplified by PCR using prim-
ers SmcR003 and SmcR004 (Table II), into pRK415 under the
control of an isopropyl--D-thiogalactopyranoside (IPTG)-in-
ducible promoter (18). When smcR was induced by IPTG, the
elastase activity and vvpE transcript of HS03 (pHS105) in the
stationary phase were restored to levels comparable to those in
the wild type (Fig. 2). Therefore, the decreased elastase activity
of HS03 apparently resulted from the inactivation of functional
smcR rather than any polar effects on genes downstream of
smcR.
The elastase activity in the smcR rpoS double mutant HS04
was present at 2 units (Fig. 2), which was much lower than
that reached by the wild type, yet indistinguishable from that
in the rpoS single mutant KP101 (Fig. 2). The expression of
vvpE remained low unless the functional gene product of rpoS
was provided and was completely unaffected by the additional
inactivation of smcR. Furthermore, it was noted that the re-
pressed level of elastase in HS04 was not restored at all by the
reintroduction of either SmcR (pHS105) or RpoS (pHS0001)
(Fig. 2), indicating that SmcR is capable of activating the ex-
pression of vvpE only when RpoS is present and that SmcR
exerts its effects on vvpE expression through a promoter whose
activity depends on RpoS.
Effect of SmcR on vvpE Expression Is Mediated through the
RpoS-dependent Promoter—A previous study suggested that
the expression of vvpE is directed by two different types of
promoters, PL and PS, in a growth phase-dependent manner
(9). The activity of PS, induced only when the cells enter the
stationary phase, was entirely dependent on RpoS and was also
under the positive control of CRP (Fig. 3). As such, the presence
of at least two promoters for vvpE raises the question of
whether the regulation by SmcR is through the stationary
phase-induced promoter (PS) or the constitutive promoter (PL).
To answer this question, the activities of PL and PS in the wild
type and isogenic smcR mutant were determined by primer
extension analyses. As such, RNA was prepared from cultures
grown to the log or stationary phase. PL activities were ob-
served in the cells grown to both the log and stationary phases.
In addition, when determined based on the intensity of the
bands of the reverse transcripts, the PL activities were not
significantly changed by the inactivation of smcR. These re-
sults are consistent with our previous observations that the
activity of PL is constitutive regardless of the growth phase and
is apparently independent of the regulatory factors required for
the activation of PS (9). In contrast to PL, no band correspond-
ing to PS activity was detected in the RNA from the smcR
mutant. Accordingly, these results indicate that SmcR is in-
volved in the regulation of vvpE transcription by activating the
RpoS-dependent promoter (PS) (Fig. 3).
Effect of CRP on vvpE Expression Is Mediated through
SmcR—When the crp mutant DI0201 was compared with its
parental wild type during stationary growth, it produced less
elastase, and the level of elastase activity was almost 4-fold less
than in the wild type (Fig. 4). The levels of elastase activity and
vvpE transcript in the smcR crp double mutant DI0202 were
determined and found to be lower than those in the crp single
mutant DI0201, yet indistinguishable from those in the smcR
single mutant HS03. As such, these results indicated that the
mutation of crp reduced the activity of PS; however, the addi-
tional inactivation of crp had no influence on the PS activity in
the smcR mutant. For the complementation of DI0202, the
plasmid pKC0004 was constructed by subcloning crp in a sim-
ilar way to the construction of pHS105 (9). The transfer and
induction of pKC0004 provided the smcR crp double mutant
DI0202 with an increased level of CRP. Western blot analysis
revealed that the level of CRP in the DI0202 (pKC0004) cells
was relatively higher than that in the smcR single mutant
HS03 cells, in which all CRP molecules are products of the crp
gene carried on the chromosome and expressed by its own
promoter (Fig. 4). However, the repressed levels of elastase
activity and vvpE transcript were not recovered at all in
DI0202 (pKC0004) (Fig. 4), and the levels were almost identical
to those in HS03. Therefore, these combined results indicate
TABLE II
Oligonucleotides used in this study
Oligonucleotide Oligonucleotide sequence (5–3)a Locationb Use
VVPE9905 GACGTTGATTGAGTTTCATTATCG 69–92 Primer extension
VVPE001 GTAGGTACCACTCAAGCTGACGAACTTGATC 335 to 314 Promoter deletion
VVPE002 GTTGGTACCCTGTCCCATTTATCTTATTGATA 221 to 199 Promoter deletion
VVPE003 CTTGGTACCTTATTGATAAATCTGCGTAAA 207 to 187 Promoter deletion
VVPE004 CAGGTACCAGTGAGATGGATTCTTTGTATAACA 114 to 90 Promoter deletion
VVPE005 GTTGGTACCATTTTCTGAACCATGGTTGTTG 28 to 10 Promoter deletion
VVPE006 GAATCTAGACCGATACAGAAGGCAGATCGGC 392–413 Promoter deletion
VVPE021 AGAATGGCGATTTTCATAG 300 to 282 Gel mobility shift assay
VVPE022 GAATCCATCTCACTGCGA 118 to 101 Gel mobility shift assay
VVPE023 CGTCGAGAATGGCGATTTTC 305 to 285 DNase I footprinting
VVPE024 AGCCAACTTCACCAAAAAA 55 to 36 DNase I footprinting
SmcR001 ATGGACTCAATCGCAAAGA Chromosomal DNA Mutant construction
SmcR002 TAGGCGTGCTCGCGTTTA Chromosomal DNA Mutant construction
SmcR003 GAATCTAGAAAGGAAACAACCTATGGACTC Chromosomal DNA Complementation of smcR
SmcR004 GAAGAATTCCCTTGATATGAGGTTACTGG Chromosomal DNA Complementation of smcR
HIS-SmcR001 ATACTGCAGATGGACTCAATCGCAAAGAG Chromosomal DNA Amplification of smcR
HIS-SmcR002 TATGAATTCTATTCGTGCTCGCGTTTATAG Chromosomal DNA Amplification of smcR
a Regions of oligonucleotides not complementary to the corresponding genes are underlined.
b Shown are the oligonucleotide positions, where 1 is the transcription start site of vvpE.
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that a variation in the cellular level of CRP did not affect the
activity of PS unless SmcR was also present, thereby suggest-
ing that the activation of PS by CRP is mediated through
SmcR.
CRP and SmcR Coactivate vvpE Expression Synergisti-
cally—To determine whether an increased amount of SmcR
would compensate for a lack of CRP in the activation of PS, the
smcR expression plasmid pHS105 was introduced into the
smcR crp double mutant DI0202. When smcR was induced by
IPTG, the cellular level of SmcR in DI0202 (pHS105) was
higher than that in the crp single mutant DI0201 (Fig. 4).
However, the levels of elastase and vvpE transcript in DI0202
(pHS105) were only one-fourth of those in the wild type, yet
were indistinguishable from the levels in DI0201 (Fig. 4), indi-
cating that SmcR, even when overproduced, is unable to acti-
vate PS to the wild-type level in the absence of CRP. Thus, even
though the effect of CRP on vvpE expression occurred through
SmcR and was weaker than that of SmcR, overproduced SmcR
was still unable to compensate for the lack of CRP.
Accordingly, it would seem that the activation of vvpE to the
wild-type level requires both CRP and SmcR simultaneously.
CRP alone had little effect on vvpE expression with PS, as the
elastase activity of the cells carrying only CRP was 2 units,
which was indistinguishable from the basal level (i.e. without
both activators). Cells carrying only SmcR expressed 3 times
more vvpE than the basal level (6 units of elastase) (Fig. 4).
The elastase activity in the wild type, in which both CRP and
SmcR functioned together, was 25 units, which was even
greater than the sum of the vvpE expression achieved by each
activator alone. Therefore, these combined results suggest that
CRP and SmcR function synergistically to coactivate the ex-
pression of vvpE with the RpoS-dependent promoter (PS).
CRP and SmcR Function Cooperatively Rather than Sequen-
tially to Activate vvpE Expression—Different mechanisms are
possible for this coactivation of PS by CRP and SmcR. For
example, multiple activators function sequentially in a regula-
tory cascade, where one activator influences the accumulation
of another regulator(s), which in turn is directly responsible for
the activation of PS. To test this possibility, the cellular levels
of RpoS, CRP, and SmcR were determined in the same amount
of total protein isolated from the wild type and its isogenic
mutants (Fig. 5).
In the wild type, no RpoS was detected in the log phase, yet
it appeared in stationary-phase cells. This result was consist-
ent with the observation that the activity of the RpoS-depend-
ent promoter (PS) appeared only in stationary-phase cells.
Western blot analysis revealed that the cellular levels of RpoS
in crp and smcR mutant stationary-phase cells were not signif-
icantly lower than those in the wild type, indicating that nei-
ther CRP nor SmcR influences the accumulation of RpoS, at
least in stationary-phase cells. From this result, it is unlikely
that CRP or SmcR indirectly activates the activity of PS by
increasing the cellular level of RpoS, which is required for PS
activity.
The level of SmcR was also higher in stationary-phase cells
than in log-phase cells. In contrast to RpoS and SmcR, the
cellular levels of CRP did not vary significantly in cells in
different growth phases (Fig. 5). We noted that neither activa-
tor affected the cellular level of the other, i.e. compared with
the wild type, the smcR mutant strain did not exhibit any
significant changes in the cellular level of CRP and vice versa.
Despite the observation that the activation of PS by CRP was
mediated by SmcR, the above result indicates that the influ-
ence of CRP on PS is not the result of increasing the level of
SmcR in cells. Consequently, it would appear that CRP and
SmcR function cooperatively to activate PS activity rather than
sequentially in a regulatory cascade.
FIG. 2. Dependence of elastase production on SmcR and RpoS. Cultures of the wild type (WT) and isogenic mutants were grown in LBS,
and then samples removed during the stationary phase (A600  2.0) were analyzed for their elastase activity and vvpE transcript levels. For a
complementation test, when the cultures reached an A600 of 0.6, IPTG was added to a final concentration of 0.1 mM to induce the expression of
recombinant smcR (i.e. on pHS105) or rpoS (i.e. on pHS0001) as indicated. Details for determining the elastase activity and a Northern blot of the
vvpE transcript are given under ‘‘Experimental Procedures.’’ Error bars represent S.E.
FIG. 3. Activities of vvpE promoters PL and PS in V. vulnificus
with different genetic backgrounds. The PL and PS activities were
determined separately by primer extension of the RNA derived from the
wild type (WT) and isogenic mutants as indicated. Total RNA was
prepared from the log phase (L; A600  0.6) and stationary phase (S;
A600  2.0) of each culture. G, A, T, and C represent the nucleotide
sequencing ladders of pKC980. Asterisks indicate the transcription
start sites for PL (A) and PS (C).
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Deletion Analysis of the vvpE Promoter Region—To delineate
the cis-DNA sequences in the PS promoter region required for
CRP and SmcR activation, transcriptional fusions of the puta-
tive vvpE regulatory region were made with the reporter gene
luxAB. The pHS reporter fusions are shown in Fig. 6A. The
reporter constructs were transferred into the wild-type strain,
crp mutant KC74, and smcR mutant HS03. Culture lumines-
cence was used to quantify the capacity of each vvpE upstream
fragment to activate the transcription of vvpE.
For the wild-type strain containing pHS201, a plasmid car-
rying an intact regulatory region, the luminescence activity
was 4.5 	 106 relative light units (Fig. 6B). The light pro-
duced by both the crp and smcR mutants carrying pHS201 was
significantly reduced, supporting the hypothesis that the ex-
pression of PS is dependent on CRP and SmcR. The lumines-
cence was also reduced in the strains carrying pHS202. More-
over, the levels of luminescence in ATCC29307 (pHS202) and
KC74 (pHS202) did not significantly differ, yet were higher
than those in HS03 (pHS202). Similar results were observed
when comparing the luminescence between the wild type and
KC74 cells containing pHS203 (Fig. 6B). As such, these data
indicate that the sequences necessary for the activation of PS
by CRP are absent in the vvpE upstream regions carried in
pHS202 and pHS203. Because the vvpE upstream regions in
pHS202 and pHS203 were deleted up to 221 and 207 bp,
respectively, it is reasonable to conclude that the important
cis-acting element for the activation of PS by CRP ranges from
221 to 207 bp upstream of the PS transcription start site.
When transformed with pHS204, the levels of luminescence
in the wild-type and smcR mutant cells were comparable. The
magnitude of the decrease in luminescence from pHS201 in the
smcR mutant was similar to that observed in cells carrying
pHS204, indicating that the vvpE upstream region in pHS204
does not harbor any cis-acting elements essential for the acti-
vation of PS by SmcR. Because the 5-end of the vvpE upstream
region was shortened to 114 bp in pHS204, this suggests that
the upstream region extending from 207 to 114 bp from the
transcription start site of PS is required for SmcR activation of
PS. The levels of luminescence in the strains containing
pHS205 with further shortening in the 5-end of the PS up-
stream region to 28 bp resulted in a complete loss of the
activity of PS. Therefore, these results reveal that the func-
tional promoter region extending from 221 to 114 bp con-
tains consecutively the cis-elements necessary for CRP and
SmcR to activate PS.
CRP and SmcR Specifically Bind the vvpE Promoter—It was
clear that CRP and SmcR affect the expression of vvpE and
that the sequences located between about 221 and 114 bp
upstream of the transcription start site of PS are required for
CRP and SmcR to activate PS. However, there are still several
possible ways for CRP and SmcR to affect the activity of PS.
One is by binding directly to the upstream region of PS to
stimulate PS activity, whereas another is for CRP and SmcR to
either increase or decrease the cellular level of an unidentified
trans-acting factor(s), which in turn binds directly to the vvpE
regulatory region.
To determine whether SmcR and CRP directly bind the vvpE
promoter, a 200-bp DNA fragment encompassing residues
221 and 114 (extending from residues 300 to 101) was
labeled, incubated with increasing amounts of CRP, and then
subjected to electrophoresis. As shown in Fig. 7A, the addition
of CRP at 100 nM resulted in a shift of the 200-bp DNA frag-
ment to a single band with slower mobility. The binding of CRP
was also specific because assays were performed in the pres-
ence of 1 g of poly(dI-dC) as a nonspecific competitor (Fig. 7A,
first through fifth lanes). In a second gel mobility shift assay,
an additional unlabeled 200-bp DNA fragment was used as a
self-competitor DNA to confirm the specific binding of CRP to
the vvpE promoter (Fig. 7A, sixth through ninth lanes). The
unlabeled 200-bp DNA was found to compete for binding with
FIG. 4. SmcR and CRP cooperate synergistically to control vvpE. Samples were removed from cultures of the wild type (WT) and isogenic
mutants grown to the stationary phase (A600  2.0). The samples were analyzed to determine elastase activity, vvpE transcript, and CRP or SmcR
protein levels. Details for determining the elastase activity and a Northern blot of the vvpE transcript are described under ‘‘Experimental
Procedures.’’ The cellular levels of CRP and SmcR were determined by Western blot analyses using the IgG fractions of rat anti-V. vulnificus CRP
and rat anti-V. vulnificus SmcR sera, respectively. For complementation tests, when the cultures reached an A600 of 0.6, IPTG was added to a final
concentration of 0.1 mM to induce the expression of recombinant crp (i.e. on pKC0004) or smcR (pHS105) as indicated. Error bars represent
the S.E.
FIG. 5. Cellular levels of SmcR, CRP, and RpoS are unaffected
by one other. The wild type (WT) and rpoS, crp, and smcR mutants of
V. vulnificus strains were grown in LBS to A600 of 0.6 (log phase (L))
and 2.0 (stationary phase (S)). The cells were then examined for the
presence of RpoS, CRP, and SmcR proteins by Western blot analyses
using the IgG fractions of rat anti-V. vulnificus RpoS, rat anti-V. vulni-
ficus CRP, and rat anti-V. vulnificus SmcR sera, respectively.
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CRP in a dose-dependent manner, indicating that CRP binds
specifically to the vvpE regulatory region.
In similar DNA binding assays, SmcR also displayed specific
binding to the vvpE promoter (Fig. 7B). Based on the concen-
tration of SmcR that was required to retard 50% of the labeled
probe, it was estimated that the dissociation binding constant
(Kd) for SmcR was 80 nM (Fig. 7C). This Kd for SmcR was
lower than the Kd for CRP, which was 120 nM, determined in
the same way. This result suggested that the affinity of SmcR
for the vvpE promoter DNA was higher than that of CRP. In
both gel mobility shift assays, the vvpE promoter region did not
form any intermediate bands that were chased away to a
slower migrating band at higher concentrations of the proteins.
This pattern of migration suggests that a single, if not identi-
cal, binding site for CRP and SmcR is present in the vvpE
promoter region.
Although their binding affinities were different, it was obvi-
ous that both CRP and SmcR were able to bind to the vvpE
promoter region by themselves in the absence of the other, i.e.
in an independent manner. To further determine whether
there is cooperative binding between CRP and SmcR with the
vvpE promoter DNA, binding assays were conducted with ei-
ther one or both of the proteins. When both CRP and SmcR
were present in the reaction, most of each band representing
DNA bound with either CRP or SmcR disappeared, whereas a
slower moving band representing DNA bound with both of the
proteins was observed (Fig. 8). These results indicate that CRP
and SmcR can bind simultaneously to the vvpE promoter re-
gion and that there is some cooperative interaction in their
binding to the DNA.
Identification of Binding Sites for CRP and SmcR Using
DNase I Protection Analysis—To determine the precise location
of the CRP-binding site in the vvpE regulatory region, a DNase
I footprinting experiment was performed using a 270-bp DNA
fragment extending from 305 to 36 bp. As shown in Fig. 9A,
the DNase I footprinting revealed a clear protection pattern by
CRP in the upstream region of vvpE between 229 and 210
bp (Figs. 9A and 10). Several nucleotides revealed an enhanced
cleavage, which is frequently observed in DNase I protection
analyses of CRP-binding sites (19). The protected region over-
lapped with a consensus sequence for CRP binding extending
from 228 to 213 bp (Figs. 9A and 10).
The sequences for binding of SmcR to the vvpE promoter
were also mapped using the same 270-bp fragment by DNase I
footprinting (Fig. 9B). The SmcR footprint extended from ap-
proximately 207 to 189 bp in the coding strand and from
approximately 209 to 187 bp in the noncoding strand (Figs.
9B and 10). No other protected regions were observed in this
FIG. 6. Localization of binding sites for CRP and SmcR in the vvpE promoter. A, construction of vvpE-lux fusion pHS plasmids. PCR
fragments carrying the regulatory region of vvpE with deletions were subcloned into pHK0011 (9) to create each pHS reporter. Solid lines, the
upstream region of vvpE; shaded blocks, the vvpE coding region; open blocks, the luxAB DNA. The wild-type vvpE regulatory region is shown on
top with the proposed 10 and 35 regions and the binding sites for CRP (CB) and SmcR (SB). B, cellular luminescence determined from the wild
type (shaded bars), isogenic crp mutant (closed bars), and isogenic smcR mutant (open bars) of V. vulnificus containing each pHS reporter as
indicated. Cultures in the stationary phase of growth (A600  2.0) were used to measure the cellular luminescence. Error bars represent the S.E.
RLU, arbitrary relative light units.
FIG. 7. Gel mobility shift assay for binding of SmcR and CRP to the vvpE regulatory region. For A and B, a 200-bp DNA fragment of
the upstream region of vvpE was radioactively labeled and then used as a DNA probe. The radiolabeled fragments (7 nM) were mixed with
increasing amounts (0, 50, 100, 150, and 200 nM in the first through fifth lanes, respectively) of CRP (A) or SmcR (B) and then resolved on a 5%
polyacrylamide gel. For the binding of CRP, cAMP was included in all of the reaction mixtures at a final concentration of 1 mM. For competition
analysis, the same but unlabeled 200-bp DNA fragment was used as a self-competitor DNA. Various amounts of the self-competitor DNA were
added to the reaction mixture containing the labeled DNA (7 nM) prior to the addition of 200 nM CRP (A) or SmcR (B). The DNA probe was incubated
with 35, 70, 175, and 350 nM competitor DNA (sixth through ninth lanes, respectively). B, bound DNA; F, free DNA. For C, the relative affinities
of CRP and SmcR for the upstream region of vvpE were compared using the data from A and B, respectively. The concentration of bound DNA was
calculated and plotted against the concentration of the proteins added. Each arrow points to the position of half-maximal binding corresponding
to the Kd. , CRP; f, SmcR.
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fragment, supporting the previous assumption that SmcR
binds to only one site in the vvpE promoter. Inspection of the
sequence protected by SmcR (Fig. 10) revealed neither inverted
nor tandem repeats, which are often found in binding sites for
other transcriptional activators. These observations confirm
that CRP and SmcR activate PS directly by binding to the
upstream region of vvpE and that the proteins bind to two
distinct sites. Although the binding sites did not overlap each
other, they were close enough to suggest a possible interaction
between the two proteins present at the binding sites.
In summary, it is apparent that CRP and SmcR collaborate
synergistically to activate the expression of vvpE with the
RpoS-dependent promoter (PS). In addition, CRP and SmcR
seem to function cooperatively to stimulate PS activity rather
than sequentially in a regulatory cascade. Finally, CRP and
SmcR exert their effect on PS activity by directly binding to two
distinct sites centered 220 and 198 bp upstream of the
transcription start site, respectively.
DISCUSSION
The diseases resulting from infection with V. vulnificus are
remarkable as regards their invasive nature, ensuing severe
tissue damage, and rapidly fulminating course. Therefore, un-
derstanding the molecular pathogenesis of this pathogen is
critical in the development of improved treatment and preven-
tion, as well as in the elucidation of how certain bacteria can
cause such extensive damage. Among the putative virulence
factors that have been proposed to account for the destructive
nature of V. vulnificus infections is an elastolytic metallopro-
tease. Several different lines of evidence have led to the hy-
pothesis that elastase is an important, if not essential, viru-
lence factor for V. vulnificus. Nonetheless, to further verify the
role of elastase in pathogenesis, it is essential to understand
the mechanism whereby the expression pattern and level of
elastase are modulated during infection. We previously dem-
onstrated that vvpE expression is induced by the RpoS-depend-
ent promoter (PS) in the stationary phase, which is under the
control of CRP (9). Recently, it was reported that the SmcR of
V. vulnificus is also involved in the regulation of vvpE (10).
However, no definitive analysis of the roles the two regulatory
proteins in the activation of vvpE expression has been reported
in previous studies.
As a result of this study, it is apparent that SmcR activates
the expression of the V. vulnificus elastase gene by binding
directly to PS. SmcR is a homolog of V. harveyi LuxR, which is
known to regulate the V. harveyi lux operon in a cell density-
dependent manner (quorum-sensing regulatory system) (20).
Recently, increasing numbers of LuxR homologs have been
identified in different Vibrio spp. such as Vibrio cholerae,
Vibrio parahaemolyticus, and Vibrio anguillarum (21–24). Al-
though LuxR homologs from Vibrio spp. exhibit high levels of
identity (72–92% in amino acid sequences) (20), the specific
features of their functions clearly differ, such that the regula-
tory proteins act as repressors with some promoters and as
activators with others. Null mutations of LuxR homologs result
in a broad range of pleiotropic phenotype changes, indicating
that LuxR homologs are apparently novel global regulators
whereby the transcription of a set of different genes is regu-
lated. However, the greatest limitation has been to assess
direct binding of LuxR homologs to DNA in vitro, and thus, a
consensus sequence(s) for the binding of the proteins has not
yet been identified. HapR is known to bind to the V. cholerae
aphA promoter region spanning from 85 to 58 bp (22). Our
report of the sequence of the upstream region of vvpE for SmcR
binding is the first known report of the DNA sequence for the
binding of SmcR. The SmcR-binding site in the vvpE promoter
does not appear to be conserved with these binding sites. None-
theless, it has been noted that the sequences for the SmcR-
binding site are highly AT-rich, as commonly observed in
LuxR- and HapR-binding sites (Fig. 10) (22, 25).
This study has shown that the expression of the V. vulnificus
elastase gene is dependent on CRP. The CRP-binding site is
centered 220 bp upstream of the transcription start site of PS.
However, 220 bp upstream of the transcription start site is
unusually distant for direct activation by CRP (26). To our
knowledge, a CRP role in activation by direct binding this far
upstream of the promoter has not been previously reported.
The binding sites for CRP found for any previously character-
ized promoters, including galP1, lacP1, malTp, ansB, and
uhpTp, are centered not farther than 121.5 bp upstream of
their transcription start sites (27–30). For activation of papBA
in E. coli, where CRP binding at 215.5 bp is the most excep-
tional distant binding reported, CRP without Lrp (leucine-
responsive regulatory protein) provides little activation. In this
example, Lrp binds to multiple sites extended between CRP-
and RNA polymerase (RNAP)-binding sites. Furthermore, Lrp
is proposed to bring CRP into contact with the C-terminal
domain of the -subunit (-CTD) of RNAP by bending (forming
a DNA loop) the promoter DNA (31). But for vvpE, only one
SmcR-binding site at198 bp has been detected between CRP-
and RNAP-binding sites (Fig. 10), and SmcR is not able to bend
the vvpE promoter DNA (data not shown).
Although transcriptional synergy by multiple activators is
often found in eukaryotes, relatively few examples of synergy
in prokaryotic organisms have been reported (30, 32). Spe-
cially, synergistic coactivation with CRP and LuxR homologs
has not yet been reported. In this study, CRP did not activate
PS by itself, but only in conjunction with SmcR. SmcR that
bound to the vvpE promoter just downstream of the CRP-
binding site activated PS as a solitary regulator, albeit not to
the wild-type level. It was obvious that activation of PS to the
wild-type level required both CRP and SmcR. There are several
possible roles for CRP in this synergistic coactivation of PS.
One involves enhancing the ability of SmcR to bind to its
recognition site. Cooperative binding between SmcR and CRP
with the vvpE promoter DNA was observed, thereby potentially
supporting this hypothesis (Fig. 8). However, as observed in
Fig. 4, overproduced SmcR failed to compensate at all for a lack
of CRP. Although the mechanism for the coactivation of PS by
CRP and SmcR still remains unclear, this indicates that the
role of CRP is more than simply enhancing SmcR binding to
PS. For example, CRP may stabilize the interaction, if any,
between SmcR and RNAP. Experiments to further examine the
FIG. 8. Binding of SmcR and CRP to the vvpE regulatory re-
gion by cooperative interaction. Gel mobility shift assays were
performed under the same conditions as described in the legend to Fig.
7, except that 100 nM SmcR, 100 nM CRP, or a mixture of 100 nM SmcR
and 100 nM CRP was added to the radiolabeled fragments as indicated.
The positions of the unbound fragments (F) and the positions of the
fragments retarded by SmcR (B1), CRP (B2), or mixture of SmcR and
CRP (B3) are indicated by arrows.
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exact role of CRP in the coactivation of PS by SmcR are now
under way.
The multifaceted nature of the host-pathogen interaction
indicates that more than one virulence factor is typically in-
volved in pathogenesis (33). Most of these virulence factors act
cooperatively to obtain maximum effectiveness in the patho-
genesis, and their expression is coordinately controlled by a
common regulatory system in response to environmental sig-
nals (34). It is likely that multiple global regulators may pro-
vide the additional levels of control for precisely coordinated
expression of the virulence factors. CRP, which is a central
regulator of energy (catabolic) metabolism, would make expres-
sion of virulence factors metabolically coordinated, such that
the energy and resources in cells should be used in the most
efficient way possible during pathogenesis. Indeed, CRP regu-
lation has been observed in the synthesis of the virulence
factors of several pathogenic bacteria (16, 35–37). Recently,
quorum sensing has been also implicated as an important
global regulator controlling the expression of numerous viru-
lence genes in bacterial pathogens (for a recent review, see Ref.
38). It is not yet clear whether SmcR acts in a cell density-de-
pendent manner or not; however, LuxR homologs from Vibrio
spp. are proposed to sense the place where their cell densities
reach higher than critical levels (38). Although further under-
standing of the implications of the collaboration between CRP
and SmcR in terms of pathogenesis of V. vulnificus will await
additional works, this metabolically and spatially coordinated
regulation would facilitate cooperation of the virulence factors
and would be crucial for the overall success of the organism
during pathogenesis.
The sequences of the intervening DNA between the SmcR-
and RNAP-binding sites (35 and 10 regions) of PS were
analyzed (Fig. 10). A UP element for the binding of the -sub-
unit of RNAP was present at an appropriate distance from the
transcription start site (Fig. 10). The assigned sequences for
the UP element (AAAACATTTTTTTGGTGAAGTT) scored an
86% homology to the UP element consensus sequences of the
promoters recognized by the -CTD of the RNAP in E. coli (39).
It has been suggested that class I activators stimulate tran-
scription with promoters by contacting the -subunit of RNAP
(40). However, it seems likely that 220 and 198 bp upstream of
the transcription start site are still unusually large distances
for class I activation of promoters. One possible way that CRP
and/or SmcR (binding at approximately 220 and 198 bp,
FIG. 9. Sequences for binding of CRP and SmcR to the vvpE promoter. A, shown are the results from DNase I protection analysis of CRP
binding to the vvpE regulatory region. The labeling of the vvpE regulatory region was performed on both the coding and noncoding strands as
indicated. 32P-Labeled 270-bp fragments were incubated with increasing amounts of CRP and then digested with DNase I. Lane 1, no CRP added;
lanes 2–4, CRP at 200, 400, and 600 nM, respectively. The nucleotides showing an enhanced cleavage in the presence of CRP are indicated by black
boxes, whereas the regions protected by CRP are indicated by open boxes. B, to analyze the SmcR binding to the vvpE promoter using DNase I
footprinting, the same experimental conditions were used, except that cAMP was omitted. Lane 1, no SmcR added; lanes 2–4, SmcR at 200, 400,
and 600 nM, respectively. Protection by SmcR is indicated by shaded boxes. For both A and B, G, A, T, and C represent the nucleotide sequencing
ladders of pKC980.
FIG. 10. Sequence analysis of the
vvpE upstream region. The transcrip-
tion start sites of the log (PL) and station-
ary (PS) phases are indicated by bent ar-
rows. The positions of the putative 10
and 35 regions are underlined for PS.
The sequences proposed for the binding
sites of CRP (CB) and SmcR (SB) are rep-
resented by lines and shaded boxes, re-
spectively. The conserved nucleotide se-
quences for the binding of CRP, IHF, and
the -CTD of RNAP are indicated above
the V. vulnificus DNA sequence in upper-
case letters. The ATG translation initia-
tion codon and the putative ribosome-
binding site (AGGA) are indicated in
boldface. W, A or T; R, A or G; N, any base.
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respectively) directly contacts the -CTD of RNAP is by form-
ing a loop to bring the activators close to the RNAP. Because we
did not observe that SmcR induced a significant DNA bending
of the vvpE promoter region (data not shown), this implies that
another factor(s), as yet unidentified, may be involved in acti-
vation of PS to convey the remote effects of CRP and SmcR to
RNAP. Consistent with this, the two sequences of the interven-
ing region revealed reasonable homologies to the integration
host factor (IHF)-binding consensus sequences (Fig. 10) (41).
IHF is an asymmetric histone-like protein that binds and bends
the DNA at specific sequences. IHF-induced bending facilitates
a protein-protein interaction between an upstream activator
and RNAP (41). However, additional works are needed to clar-
ify whether these regions really act as IHF recognition sites
and whether IHF is really involved in the activation of PS by
forming a DNA loop between CRP and/or SmcR and RNAP.
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